Hoth Therapeutics Inc. [NASDAQ: HOTH] plunged by -$0.16 during the normal trading session on Wednesday and reaching a high of $2.47 during the day while it closed the day at $1.74. The company report on April 26, 2023 at 8:18 AM that Hoth Therapeutics and Algorithm Sciences Execute Letter of Intent to Merge.
Anthony Zook, formerly of Astra Zeneca, to be named Chairman of The Board.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Mike Tilton to be named Chief Executive Officer of the Combined Company.
Hoth Therapeutics Inc. stock has also loss -15.94% of its value over the past 7 days. However, HOTH stock has declined by -66.21% in the 3 months of the year. Over the past six months meanwhile, it has lost -78.67% and lost -77.69% year-on date.
The market cap for HOTH stock reached $5.57 million, with 3.30 million shares outstanding and 3.26 million shares in the current float. Compared to the average trading volume of 762.70K shares, HOTH reached a trading volume of 3949578 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Hoth Therapeutics Inc. [HOTH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOTH shares is $9.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOTH stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Benchmark Company have made an estimate for Hoth Therapeutics Inc. shares, keeping their opinion on the stock as Speculative Buy, with their previous recommendation back on October 15, 2019.
The Average True Range (ATR) for Hoth Therapeutics Inc. is set at 0.22 The Price to Book ratio for the last quarter was 0.44, with the Price to Cash per share for the same quarter was set at 2.06.
HOTH stock trade performance evaluation
Hoth Therapeutics Inc. [HOTH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.94. With this latest performance, HOTH shares dropped by -22.67% in over the last four-week period, additionally sinking by -78.67% over the last 6 months – not to mention a drop of -88.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOTH stock in for the last two-week period is set at 32.22, with the RSI for the last a single of trading hit 27.33, and the three-weeks RSI is set at 35.35 for Hoth Therapeutics Inc. [HOTH]. The present Moving Average for the last 50 days of trading for this stock 2.3314, while it was recorded at 1.9020 for the last single week of trading, and 6.0169 for the last 200 days.
Hoth Therapeutics Inc. [HOTH]: An insightful look at the core fundamentals
Return on Total Capital for HOTH is now -194.13, given the latest momentum, and Return on Invested Capital for the company is -197.05. Return on Equity for this stock declined to -197.05, with Return on Assets sitting at -176.41.
Reflecting on the efficiency of the workforce at the company, Hoth Therapeutics Inc. [HOTH] managed to generate an average of -$3,578,426 per employee.Hoth Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 4.80.
Hoth Therapeutics Inc. [HOTH]: Insider Ownership positions
There are presently around $0 million, or 8.30% of HOTH stock, in the hands of institutional investors. The top three institutional holders of HOTH stocks are: ARMISTICE CAPITAL, LLC with ownership of 140,000, which is approximately New of the company’s market cap and around 2.90% of the total institutional ownership; HRT FINANCIAL LP, holding 11,532 shares of the stock with an approximate value of $20000.0 in HOTH stocks shares; and JANE STREET GROUP, LLC, currently with $19000.0 in HOTH stock with ownership of nearly New of the company’s market capitalization.
Positions in Hoth Therapeutics Inc. stocks held by institutional investors increased at the end of Wednesday and at the time of the Wednesday reporting period, where 8 institutional holders increased their position in Hoth Therapeutics Inc. [NASDAQ:HOTH] by around 168,048 shares. Additionally, 9 investors decreased positions by around 56,351 shares, while 5 investors held positions by with 55,033 shares. The mentioned changes placed institutional holdings at 169,366 shares, according to the latest SEC report filing. HOTH stock had 6 new institutional investments in for a total of 162,658 shares, while 9 institutional investors sold positions of 56,351 shares during the same period.